"Analgesics in Estonia" now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Thu Dec 10 2015

Analgesics was a very commonly purchased product group in Estonia as the hectic and stressful lifestyles often cause increased stress levels that result in headaches and pain. Furthermore, as more Estonians became very active in sports, injuries that cause pain required use of analgesics. In analgesics, generic products were promoted during the review period to raise peoples’ awareness about similar products across different price ranges. Nevertheless, consumers tended to prefer well-known brands over generic products or brands for which there was low awareness. This trend was also boosted by the increasing purchasing power of Estonians as the economic situation improved. Estonians continued to use stronger analgesics with a 400mg concentration as these were considered more efficient compared to 200mg products.

Full Report Details at
- http://www.fastmr.com/prod/1082063_analgesics_estonia.aspx?afid=301

Competitive Landscape

Nycomed SEFA leads in 2015 with 27% value share. The company has a wide portfolio of analgesics, among which are the well-known Ibumetin and Pamol brands. Ibumetin led systemic analgesics with a value share of 25% in 2015. The brand is very well-known among local consumers and seen as an efficient brand. The product is very well distributed and receives a great deal of marketing support. GlaxoSmithKline Plc ranked second with a 10% retail value share in 2015 as its Solpadeine brand remained widely used in Estonia.

Industry Prospects

Analgesics is not expected to see dynamic growth over the forecast period as it reached maturity in Estonia. Nevertheless, retail value sales are forecast to see marginal growth as the demand for analgesics remains. In addition, the increasing unit prices will boost sales. Regarding distribution, it is expected that internet retailing channels will take on a more prominent role in the forecast period as the channel is expected to grow rapidly during this time.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Estonia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Estonia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Estonia market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in South Korea
- Analgesics in Tunisia
- Analgesics in the United Arab Emirates
- Analgesics in Mexico
- Analgesics in Algeria

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »